Skip to content

GUIDED THERAPEUTICS INC

GTHP

CIK 0000924515

← back to feed
Revenue (TTM)
$177K
+10,857.1% YoY Q1 May 2026
Net Income (TTM)
−$2.48M
−32.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.04
+20.0% YoY Q1 May 2026
Gross Margin
64.4%
Q1 May 2026
Operating Margin
-1,109.6%
Q1 May 2026
Net Margin
-1,401.1%
Q1 May 2026
Free Cash Flow (TTM)
−$1.56M
Q1 May 2026
Cash
$731K
Q1 May 2026
Total Debt
$646K
Q1 May 2026
Shares Outstanding
96.54M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings